Rocket Pharmaceuticals has offloaded its lucrative FDA rare pediatric disease priority review voucher (PRV), striking a $180 million sale that reflects the high market demand for a speedy FDA review.

GSK (GSK) announced on Tuesday that the U.S. Food and Drug Administration (FDA) granted priority review for its marketing application for bepirovirsen, a hepatitis B therapy licensed from Ionis ...

The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder (PTSD), the latest ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Damian Garde is a ...

Even before Newcastle's 3-1 win over Brighton and Hove Albion on Saturday, it was clear to everyone associated with the club that signing a goalkeeper will be a priority in the transfer window this ...

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare ...

“I wrote this song as a lullaby for myself, but it’s for you too,” a radiant Olivia Dean tells The O2 as she breaks into pared-back and tender Messy. This is typical of her – generous and soulful, all ...

Newcastle United are planning for what could be a busy summer of transfer activity, with changes set to be made throughout the squad. Head coach Eddie Howe knows there will be interest in his top ...

Bruno Guimaraes is the most important player for Newcastle to retain this summer, but the board must act quickly. The Brazilian has served as the leader and engine of the Magpies' midfield since his ...

Johnson & Johnson secured fast-track status for its autoimmune drug Imaavy, accelerating the regulatory timeline for what could become the first approved treatment for warm autoimmune hemolytic anemia ...

The sBLA submission is based on the first interim analysis (IA1) of HERIZON-GEA-01, a global Phase 3 clinical trial designed to evaluate ZIIHERA plus chemotherapy, with and without TEVIMBRA, compared ...

Priority Tax Relief provides tax relief services to individuals wanting to resolve financial struggles. The company offers a free consultation and detailed plans for each tax relief option it provides ...